TL;DR
Medicare’s ACCESS program, launched on July 5, introduces a payment model that incentivizes AI-driven health management. While significant for healthcare innovation, the tech sector largely remains uninformed about this development.
Medicare’s new program, ACCESS, officially went live on July 5, 2023, introducing a payment model that rewards health outcomes rather than traditional activity-based reimbursements, with a focus on AI-driven care. This shift is significant because it creates a mechanism for paying AI agents that monitor and manage patients between clinical visits, a development largely unnoticed by the broader tech industry.
The ACCESS program, initiated by the Centers for Medicare & Medicaid Services (CMS), is a 10-year initiative testing a new payment framework that emphasizes measurable health outcomes for chronic conditions like diabetes, hypertension, and mental health issues. Unlike traditional Medicare, which reimburses based on clinician time, ACCESS provides predictable payments to organizations managing qualifying conditions, with full payments contingent on achieving specific health goals. This model explicitly supports AI tools and virtual care solutions, such as Pair Team’s voice AI agent Flora, which handles patient check-ins, referrals, and engagement outside of traditional visits.
Pair Team, a healthcare company focused on vulnerable populations managing chronic conditions, was accepted into the program after developing an AI-based care model that significantly reduces avoidable hospital and ER visits. The company’s CEO, Neil Batlivala, stated that the program’s design allows for AI to be integrated into care delivery in ways previously impossible under Medicare’s reimbursement rules. The program’s architects, former startup operators, deliberately crafted outcome-based payments to incentivize innovation, including AI deployment. However, the program raises concerns about data security and financial sustainability, given CMS’s mixed track record with innovation initiatives and the sensitive nature of the data involved.
Why It Matters
This development marks a fundamental shift in healthcare reimbursement, opening the door for AI-driven solutions to be financially viable at scale within Medicare. It signals a move toward outcome-based care and could accelerate the adoption of AI tools in healthcare, especially for underserved populations. For the tech industry, the lack of awareness about this program suggests a missed opportunity to engage with a major federal healthcare innovation effort, potentially delaying broader AI integration and investment in this space. The policy also challenges existing reimbursement models, which have traditionally limited AI’s role in patient management.
AI virtual health assistant for chronic conditions
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
The ACCESS program was designed by CMS Innovation Center leaders with startup backgrounds, aiming to foster competition and outcome-focused care. It reflects broader efforts to modernize healthcare payment systems, but its success remains uncertain, given CMS’s mixed history of innovation programs that often increase costs without guaranteed savings. Prior to this, Medicare’s reimbursement model has largely excluded AI and virtual care solutions from direct compensation, limiting their deployment. The program’s launch follows years of pilot projects and growing interest in AI’s potential to transform chronic care management, especially for marginalized populations facing social determinants of health barriers.
“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in regulated industries like healthcare — that’s not been the case.”
— Neil Batlivala, CEO of Pair Team
“The program is designed to test outcome-based payments that incentivize innovative care delivery, including AI and virtual solutions.”
— Abe Sutton, CMS Innovation Center Director
Medicare AI care management tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is still unclear how widely adopted AI tools will become under the new Medicare payment model, given the program’s early stage and the financial and data security risks involved. The long-term impact on healthcare costs and outcomes remains to be seen, and the level of industry awareness and engagement is currently very limited.
outcome-based healthcare monitoring devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include monitoring the program’s rollout, evaluating early data on health outcomes and cost savings, and assessing AI adoption rates among participating organizations. Further policy adjustments may follow based on initial results, and industry stakeholders may begin to recognize the potential of outcome-based AI reimbursement in healthcare.
virtual care AI solutions
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the ACCESS program?
ACCESS is a 10-year CMS initiative launched on July 5, 2023, that tests a new payment model rewarding health outcomes for chronic disease management, explicitly supporting AI and virtual care solutions.
How does the new payment model differ from traditional Medicare?
Traditional Medicare reimburses based on clinician time and activities, while ACCESS provides predictable payments based on achieving measurable health outcomes, enabling AI-driven care outside of standard visits.
Why is most of the tech industry unaware of this development?
The program’s focus on outcome-based payments and its targeted, government-specific scope mean it has not been widely publicized or understood outside healthcare policy and innovation circles.
What are the risks associated with this new model?
Risks include data security concerns given the sensitive nature of health data, financial sustainability of the program, and uncertain industry adoption levels of AI tools under the new reimbursement framework.
